Freestone Capital Holdings, LLC Bristol Myers Squibb CO Transaction History

Freestone Capital Holdings, LLC

  • $2.66 Billion
  • Q1 2025

A detailed history of Freestone Capital Holdings, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 15,633 shares of BMY stock, worth $732,406. This represents 0.04% of its overall portfolio holdings.

Number of Shares
15,633
Previous 47,964 67.41%
Holding current value
$732,406
Previous $2.71 Million 64.86%
% of portfolio
0.04%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$53.9 - $63.11 $1.74 Million - $2.04 Million
-32,331 Reduced 67.41%
15,633 $953,000
Q4 2024

Feb 06, 2025
SELL
$51.92 - $59.94 $1.6 Million - $1.85 Million
-30,906 Reduced 39.19%
47,964 $2.71 Million
Q3 2024

Nov 14, 2024
BUY
$39.66 - $51.75 $1.26 Million - $1.64 Million
31,738 Added 67.34%
78,870 $4.08 Million
Q2 2024

Nov 22, 2024
SELL
$40.25 - $52.99 $380,523 - $500,967
-9,454 Reduced 16.71%
47,132 $1.96 Million
Q2 2024

Aug 13, 2024
SELL
$40.25 - $52.99 $380,523 - $500,967
-9,454 Reduced 16.71%
47,132 $1.96 Million
Q1 2024

Nov 22, 2024
SELL
$47.98 - $54.4 $1.07 Million - $1.21 Million
-22,284 Reduced 28.25%
56,586 $3.07 Million
Q1 2024

May 14, 2024
SELL
$47.98 - $54.4 $228,720 - $259,324
-4,767 Reduced 7.77%
56,586 $3.07 Million
Q4 2023

Feb 13, 2024
SELL
$48.48 - $57.85 $251,514 - $300,125
-5,188 Reduced 7.8%
61,353 $3.15 Million
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $127,879 - $142,988
2,209 Added 3.43%
66,541 $3.86 Million
Q2 2023

Aug 09, 2023
BUY
$63.71 - $70.74 $19,558 - $21,717
307 Added 0.48%
64,332 $4.11 Million
Q1 2023

May 12, 2023
SELL
$65.71 - $74.53 $189,047 - $214,422
-2,877 Reduced 4.3%
64,025 $4.44 Million
Q4 2022

Feb 13, 2023
SELL
$68.48 - $81.09 $1.17 Million - $1.38 Million
-17,047 Reduced 20.31%
66,902 $4.81 Million
Q3 2022

Nov 09, 2022
SELL
$0.13 - $76.84 $2,238 - $1.32 Million
-17,221 Reduced 17.02%
83,949 $5.97 Million
Q2 2022

Aug 09, 2022
SELL
$72.62 - $79.98 $1.38 Million - $1.52 Million
-19,017 Reduced 15.82%
101,170 $7.79 Million
Q1 2022

May 12, 2022
SELL
$61.48 - $73.72 $111,955 - $134,244
-1,821 Reduced 1.49%
120,187 $8.78 Million
Q4 2021

Feb 14, 2022
BUY
$53.63 - $62.52 $78,299 - $91,279
1,460 Added 1.21%
122,008 $7.61 Million
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $93,192 - $109,163
1,575 Added 1.32%
120,548 $7.13 Million
Q2 2021

Aug 16, 2021
SELL
$61.91 - $67.42 $1.55 Million - $1.69 Million
-25,059 Reduced 17.4%
118,973 $7.95 Million
Q1 2021

May 17, 2021
SELL
$59.34 - $66.74 $107,820 - $121,266
-1,817 Reduced 1.25%
144,032 $9.09 Million
Q4 2020

Feb 16, 2021
BUY
$57.74 - $65.43 $995,726 - $1.13 Million
17,245 Added 13.41%
145,849 $9.05 Billion
Q3 2020

Nov 06, 2020
BUY
$57.43 - $63.64 $33,941 - $37,611
591 Added 0.46%
128,604 $7.75 Million
Q2 2020

Aug 04, 2020
BUY
$54.82 - $64.09 $450,236 - $526,371
8,213 Added 6.86%
128,013 $7.53 Million
Q1 2020

May 12, 2020
SELL
$46.4 - $67.43 $238,124 - $346,050
-5,132 Reduced 4.11%
119,800 $6.68 Million
Q4 2019

Feb 04, 2020
SELL
$49.21 - $64.19 $828,450 - $1.08 Million
-16,835 Reduced 11.88%
124,932 $8.02 Million
Q3 2019

Nov 07, 2019
BUY
$42.77 - $50.71 $1.37 Million - $1.62 Million
31,948 Added 29.09%
141,767 $7.19 Million
Q2 2019

Aug 05, 2019
BUY
$44.62 - $49.34 $4.9 Million - $5.42 Million
109,819 New
109,819 $4.98 Million
Q1 2018

May 15, 2018
SELL
$59.92 - $68.98 $207,502 - $238,877
-3,463 Closed
0 $0
Q4 2017

Feb 13, 2018
SELL
$59.94 - $65.35 $14,265 - $15,553
-238 Reduced 6.43%
3,463 $212,000
Q3 2017

Nov 14, 2017
BUY
$55.23 - $63.74 $204,406 - $235,901
3,701
3,701 $236,000

Others Institutions Holding BMY

# of Institutions
2,806
Shares Held
1.59B
Call Options Held
25.9M
Put Options Held
23.9M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.6B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Freestone Capital Holdings, LLC Portfolio

Follow Freestone Capital Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email